[AACR] Abstract PD18-02: Adjuvant Paclitaxel and Trastuzumab Trial (APT) for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive (HER2+) Breast Cancer: final 10-year analysis Closed
|
Reward30points
|
30
Biomarkers for Antibody–Drug Conjugates in Solid Tumors
30
Abstract CT016: Clinical and translational findings of pemigatinib in previously treated solid tumors with activating FGFR1-3 alterations in the FIGHT-207 study
30
Large-scale alternative polyadenylation-wide association studies to identify putative cancer susceptibility genes
30
Abstract 5250: The effect of introducing a C118S mutation into the endogenous Kras gene on early tumorigenesis
30
Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab–Auristatin Conjugate with a Wide Therapeutic Window
